Bayer's Yaz Patent Claims Are Invalid, Fed. Circ. Says
The Federal Circuit said Tuesday that two claims in Bayer HealthCare Pharmaceuticals Inc.'s patent for its Yaz contraceptive were invalid because they are obvious, siding with generic-drug makers that the company...To view the full article, register now.
Already a subscriber? Click here to view full article